Form 4 for DGX Quest Diagnostics
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0001022079-25-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-19 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $169.71 | -374 | 40.4K | -0.9% | -$63.5K | |
| 2025-02-21 | 2025-02-20 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $170.99 | -604 | 39.8K | -1% | -$103.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | F | D | 374 | $169.71 | 40,449 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2025-02-20 | S | D | 604 | $170.99 | 39,845 | D | — | — |